Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92006801 | 9200680 | 1 | I | 20130321 | 20130331 | 20130331 | EXP | GB-TEVA-393974ISR | TEVA | 50.00 | YR | F | Y | 106.00000 | KG | 20130331 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92006801 | 9200680 | 1 | PS | SERTRALINE | 1 | ORAL | U | 76465 | 50 | MG | |||||||||
| 92006801 | 9200680 | 2 | C | OLANZAPINE | 1 | D | 0 | ||||||||||||
| 92006801 | 9200680 | 3 | C | SIMVASTATIN | 1 | D | 0 | ||||||||||||
| 92006801 | 9200680 | 4 | C | SODIUM VALPROATE | 1 | D | 0 | ||||||||||||
| 92006801 | 9200680 | 5 | C | PROCYCLIDINE | 1 | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92006801 | 9200680 | 1 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92006801 | 9200680 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92006801 | 9200680 | Colitis ulcerative | |
| 92006801 | 9200680 | Rectal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |